Product focus
The current product plan defines NeuroThaw A as the entry-level standalone configuration and NeuroThaw B as the advanced configuration with right-ear PPG and app information synchronization.
COMPANY
Developing an ear-based platform with clear boundaries.
NeuroThaw is developing two configurations of a non-invasive, ear-based tVNS platform. Public company and team information has not yet been released.
Development focus
Gut health is the first intended application area in the current product plan. This does not establish clinical efficacy or authorization to make disease-related claims.
Communication standard
NeuroThaw does not present design requirements as completed verification, or development plans as certifications, availability, pricing, or launch commitments.
NEXT STEP